Keyur Parikh
About
Keyur Parikh is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, Keyur Parikh has authored 42 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cardiology and Cardiovascular Medicine, 22 papers in Surgery and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Keyur Parikh's work include Coronary Interventions and Diagnostics (17 papers), Antiplatelet Therapy and Cardiovascular Diseases (11 papers) and Cardiac Valve Diseases and Treatments (8 papers). Keyur Parikh is often cited by papers focused on Coronary Interventions and Diagnostics (17 papers), Antiplatelet Therapy and Cardiovascular Diseases (11 papers) and Cardiac Valve Diseases and Treatments (8 papers). Keyur Parikh collaborates with scholars based in India, United States and Italy. Keyur Parikh's co-authors include Carl Arneson, R. James White, Gilles Montalescot, Gregg W. Stone, C. Michael Gibson, Kenneth W. Mahaffey, Richard C. Becker, Simona Skerjanec, Dominick J. Angiolillo and Derek P. Chew and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.
In The Last Decade
Keyur Parikh
38 papers receiving 1.6k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Keyur Parikh India | 16 | 1.3k | 777 | 557 | 285 | 224 | 42 | 1.7k | ||
| Nancy Cook‐Bruns Germany | 9 | 1.5k 1.1× | 560 0.7× | 416 0.7× | 208 0.7× | 725 3.2× | 10 | 2.2k | ||
| Upendra Kaul India | 23 | 1.2k 0.9× | 1.1k 1.4× | 439 0.8× | 304 1.1× | 80 0.4× | 219 | 2.0k | ||
| M Bory France | 13 | 899 0.7× | 468 0.6× | 306 0.5× | 389 1.4× | 203 0.9× | 69 | 1.5k | ||
| Arnd B. Buchwald Germany | 20 | 1.1k 0.9× | 763 1.0× | 202 0.4× | 414 1.5× | 411 1.8× | 73 | 1.8k | ||
| Volker Schächinger Germany | 20 | 1.3k 1.0× | 669 0.9× | 345 0.6× | 512 1.8× | 55 0.2× | 64 | 1.7k | ||
| Chandra K. Nair United States | 21 | 1.4k 1.1× | 763 1.0× | 855 1.5× | 280 1.0× | 96 0.4× | 66 | 1.9k | ||
| Ad F.M. van den Heuvel Netherlands | 16 | 1.4k 1.1× | 734 0.9× | 284 0.5× | 556 2.0× | 197 0.9× | 41 | 1.8k | ||
| Yusuke Miyashita Japan | 24 | 649 0.5× | 1.5k 2.0× | 1.1k 1.9× | 183 0.6× | 241 1.1× | 107 | 2.1k | ||
| Philippe Commeau France | 17 | 785 0.6× | 1.1k 1.4× | 504 0.9× | 311 1.1× | 176 0.8× | 57 | 1.4k | ||
| Peter M. Steele Australia | 12 | 1.6k 1.2× | 878 1.1× | 1.5k 2.7× | 344 1.2× | 206 0.9× | 23 | 2.7k |
Countries citing papers authored by Keyur Parikh
Since
Specialization
Citations
This map shows the geographic impact of Keyur Parikh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keyur Parikh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keyur Parikh more than expected).
Fields of papers citing papers by Keyur Parikh
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Keyur Parikh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keyur Parikh. The network helps show where Keyur Parikh may publish in the future.
Co-authorship network of co-authors of Keyur Parikh
This figure shows the co-authorship network connecting the top 25 collaborators of Keyur Parikh. A scholar is included among the top collaborators of Keyur Parikh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keyur Parikh. Keyur Parikh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Devasia, Tom, et al.. (2024). Comparing Obtura Vascular Closure Device to Manual Compression for Achieving Hemostasis After Percutaneous Transfemoral Procedures: A Randomized Study. Journal of Endovascular Therapy. 33(1). 414–423.
2.
Lee, Vivian K., Taewoo Lee, Tanmoy Saha, et al.. (2024). An architecturally rational hemostat for rapid stopping of massive bleeding on anticoagulation therapy. Proceedings of the National Academy of Sciences. 121(5). e2316170121–e2316170121.
3.
Jose, John, Christian Juhl Terkelsen, Henrik Nissen, et al.. (2023). One-Year Outcomes after Myval Implantation in Patients with Bicuspid Aortic Valve Stenosis—A Multicentre Real-World Experience. Journal of Clinical Medicine. 12(6). 2398–2398.
4.
Dani, Sameer, et al.. (2018). CRT-100.84 Long-term Clinical Outcomes After the Treatment of Coronary Stenosis With Sirolimus-coated Balloon Angioplasty: Results From NANOLUTE Real-World Registry. JACC: Cardiovascular Interventions. 11(4). S24–S24.
5.
Parikh, Keyur, et al.. (2018). REAL WORLD CLINICAL OUTCOMES OF SIROLIMUS COATED BALLOON IN CORONARY ARTERY LESIONS: RESULTS FROM SINGLE CENTRE STUDY. Journal of the American College of Cardiology. 71(11). A1112–A1112.
6.
Bhatt, Parloop, et al.. (2017). EVALUATION OF A NEW RADIATION PROTECTION TECHNOLOGY (CARDIO-TRAP®) IN TRANSRADIAL PERCUTANEOUS CORONARY INTERVENTION PROCEDURES. Journal of the American College of Cardiology. 69(11). 1365–1365.
7.
Dani, Sameer, et al.. (2016). TCT-390 Influence of Diabetes on the Safety and Efficacy of Sirolimus Coated Balloon in a Real-World Multi-Centre Nanolutè Registry. Journal of the American College of Cardiology. 68(18). B158–B159.
8.
Parikh, Keyur, et al.. (2016). REAL-WORLD SAFETY AND OUTCOME MEASURES OF NOVEL SIROLIMUS COATED BALLOON CATHETER. Journal of the American College of Cardiology. 67(13). 225–225.
9.
Bhatt, Parloop, et al.. (2015). Unique Aspects of Coronary Artery Disease in Indian Women. Cardiovascular Drugs and Therapy. 29(4). 369–376.
10.
Bhatt, Parloop, et al.. (2015). Long-term safety and performance of the orbital atherectomy system for treating calcified coronary artery lesions: 5-Year follow-up in the ORBIT I trial. Cardiovascular revascularization medicine. 16(4). 213–216.
11.
Kaul, Upendra, Kamal Kumar Sethi, Jamshed Dalal, et al.. (2014). A multicentre retrospective study to understand anti-platelet treatment patterns and outcomes of acute coronary syndrome patients in India (TRACE). Indian Heart Journal. 66(3). 334–339.
12.
Sheth, Harsh, Faye Elliott, Michael S. Jackson, et al.. (2014). Point of care testing for improving risk- benefit ratio of aspirin and warfarin. Molecular Cytogenetics. 7(Suppl 1). I54–I54.
13.
Jing, Zhi‐Cheng, Keyur Parikh, Tomás Pulido, et al.. (2013). Efficacy and Safety of Oral Treprostinil Monotherapy for the Treatment of Pulmonary Arterial Hypertension. Circulation. 127(5). 624–633.
14.
Banai, Shmuel, Marc Schwartz, Horst Sievert, et al.. (2010). LONG-TERM FOLLOW-UP TO EVALUATE THE SAFETY OF THE NEOVASC REDUCER A DEVICE-BASED THERAPY FOR CHRONIC REFRACTORY ANGINA. Journal of the American College of Cardiology. 55(10). A98.E927–A98.E927.
15.
Seth, Ashok, Nakul Sinha, Keyur Parikh, et al.. (2009). Safety and efficacy of indigenously developed and manufactured bivalirudin in moderate/high-risk Indian patients undergoing percutaneous coronary intervention: the Bivaflo Registry.. PubMed. 60(4). 333–41.
16.
Camenzind, Edoardo, William Wijns, Laura Mauri, et al.. (2009). Rationale and design of the Patient Related OuTcomes with Endeavor versus Cypher stenting Trial (PROTECT): Randomized controlled trial comparing the incidence of stent thrombosis and clinical events after sirolimus or zotarolimus drug-eluting stent implantation. American Heart Journal. 158(6). 902–909.e5.
17.
Parikh, Keyur, et al.. (2009). Ovalum CiTop™ Expander™: a novel guidewire for crossing coronary chronic total occlusions – first-in-man (FIM) experience. EuroIntervention. 5(2). 206–211.
18.
Chevalier, Bernard, Martine Gilard, Iréne Lang, et al.. (2008). Systematic primary aspiration in acute myocardial percutaneous intervention: a multicentre randomised controlled trial of the export aspiration catheter. EuroIntervention. 4(2). 222–228.
19.
Banai, Shmuel, Keyur Parikh, Aharon Medina, et al.. (2007). Coronary Sinus Reducer Stent for the Treatment of Chronic Refractory Angina Pectoris. Journal of the American College of Cardiology. 49(17). 1783–1789.
20.
Rozenman, Yoseph, et al.. (2007). Wireless Acoustic Communication With a Miniature Pressure Sensor in the Pulmonary Artery for Disease Surveillance and Therapy of Patients With Congestive Heart Failure. Journal of the American College of Cardiology. 49(7). 784–789.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Nancy Cook‐Bruns Breakdown of academic impact, for papers by Upendra Kaul Breakdown of academic impact, for papers by M Bory Breakdown of academic impact, for papers by Arnd B. Buchwald Breakdown of academic impact, for papers by Volker Schächinger Breakdown of academic impact, for papers by Chandra K. Nair Breakdown of academic impact, for papers by Ad F.M. van den Heuvel Breakdown of academic impact, for papers by Yusuke Miyashita Breakdown of academic impact, for papers by Philippe Commeau Breakdown of academic impact, for papers by Peter M. Steele